New Pregnancy Assay Receives CE Marking and FDA Clearance
|
By LabMedica International staff writers Posted on 20 Jan 2014 |
|
![Image: The new high standard \"Access Total βhCG (5th IS)\" assay for pregnancy determination from Beckman Coulter Diagnostics (Photo courtesy of Beckman Coulter).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2014-01-20/MMS-003.gif "Image: The new high standard \\"Access Total βhCG (5th IS)\\" assay for pregnancy determination from Beckman Coulter Diagnostics (Photo courtesy of Beckman Coulter).")
Image: The new high standard \"Access Total βhCG (5th IS)\" assay for pregnancy determination from Beckman Coulter Diagnostics (Photo courtesy of Beckman Coulter).
The approved new pregnancy determination assay features a broad dynamic range and is the first to standardize to the World Health Organization's latest international standard.
To help move reproductive health management forward, Beckman Coulter Diagnostics of Beckman Coulter (Brea, CA, USA) has received the CE marking and US Food and Drug Administration (FDA) 510(k) clearance for its new "Access Total βhCG (5th IS)" assay. It is the first βhCG assay standardized to the highly purified World Health Organization (WHO) 5th International Standard (IS) for glycoprotein chorionic gonadotropin. The βhCG assay is critical in routine and emergency diagnosis as it is frequently ordered on women of childbearing-age who require treatment, which could potentially be harmful to a fetus. The expanded utility of the assay has also been CE Mark approved for Down syndrome assessment during pregnancy.
“As the first manufacturer to standardize to the WHO 5th IS, the new βhCG assay is an example of Beckman Coulter’s continuing dedication to lead the way in this important diagnostic field,” said John Blackwood, senior vice president of Product Management for Beckman Coulter Diagnostics; “The new assay is just one example of the innovations that comprise Beckman Coulter’s reproductive health portfolio—the most comprehensive immunoassay reproductive panel available on the market.”
The assay features a broad dynamic range with automatic onboard dilution capability, reducing the need for manual sample dilutions. As a part of the standardization, reference ranges have been updated to include additional populations that include women over the age of 40, postmenopausal women, and men. Additionally, in response to changing laboratory environments and the challenges faced in collecting serum samples, Beckman Coulter has further improved the Total βhCG (5th IS) to make it more resilient to preanalytical factors.
"Access" reproductive solutions are part of a comprehensive assay menu featured on the Access and UniCel Immunoassay Systems.
Related Links:
Beckman Coulter
 Rapid Test.jpg)
To help move reproductive health management forward, Beckman Coulter Diagnostics of Beckman Coulter (Brea, CA, USA) has received the CE marking and US Food and Drug Administration (FDA) 510(k) clearance for its new "Access Total βhCG (5th IS)" assay. It is the first βhCG assay standardized to the highly purified World Health Organization (WHO) 5th International Standard (IS) for glycoprotein chorionic gonadotropin. The βhCG assay is critical in routine and emergency diagnosis as it is frequently ordered on women of childbearing-age who require treatment, which could potentially be harmful to a fetus. The expanded utility of the assay has also been CE Mark approved for Down syndrome assessment during pregnancy.
“As the first manufacturer to standardize to the WHO 5th IS, the new βhCG assay is an example of Beckman Coulter’s continuing dedication to lead the way in this important diagnostic field,” said John Blackwood, senior vice president of Product Management for Beckman Coulter Diagnostics; “The new assay is just one example of the innovations that comprise Beckman Coulter’s reproductive health portfolio—the most comprehensive immunoassay reproductive panel available on the market.”
The assay features a broad dynamic range with automatic onboard dilution capability, reducing the need for manual sample dilutions. As a part of the standardization, reference ranges have been updated to include additional populations that include women over the age of 40, postmenopausal women, and men. Additionally, in response to changing laboratory environments and the challenges faced in collecting serum samples, Beckman Coulter has further improved the Total βhCG (5th IS) to make it more resilient to preanalytical factors.
"Access" reproductive solutions are part of a comprehensive assay menu featured on the Access and UniCel Immunoassay Systems.
Related Links:
Beckman Coulter
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Stand-Alone Disc Remover
NS96
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test
Latest Immunology News
- Blood Test Predicts Survival in Liver Cancer Patients
- Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy
- Portable Device Analyzes White Blood Cell Activity to Monitor Cancer Patients’ Health
- New Test Detects Return of Blood Cancer a Year Earlier
- Universal Blood Test Could Predict Organ Transplant Outcomes with Unprecedented Accuracy
- AI Tool Predicts Cancer Patients’ Response to Immunotherapy
- Molecular Profiling Improves Diagnosis for Children with High Risk Cancers
- Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients
- AI Predicts Tumor-Killing Cells with High Accuracy
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
Channels
Clinical Chemistry
view channel.jpg "Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)")
POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more
Screening Tool Detects Multiple Health Conditions from Single Blood Drop
Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more
Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more
Molecular Diagnostics
view channel
Non-Invasive Test Detects Up To 42 Solid Tumors and Five Blood Cancers in Blood and Urine Samples
Cancer is now responsible for nearly 1 in 6 deaths worldwide. Each year, over 14 million people are diagnosed with cancer, and this number is expected to surpass 21 million by 2030. A major issue is that... Read more
New Quantitative Testing System for Coronavirus Detection Could Also Diagnose Other Viral Illnesses
The COVID-19 pandemic highlighted the critical role of disease testing. Over the past few years, most people have undergone PCR (Polymerase Chain Reaction) or ELISA (Enzyme-Linked Immunosorbent Assay) tests.... Read more.jpg "Image: TAGS technology enables syndromic panel testing on the high throughput molecular diagnostic analyzers cobas 5800, 6800 and 8800 (Photo courtesy of Roche)")
Single PCR Test Simultaneously Detects 12 Respiratory Viruses in Same Patient Sample
Many respiratory illnesses share similar symptoms, making diagnosis challenging. As respiratory outbreaks and antibiotic resistance rise, timely and accurate diagnosis is crucial for providing optimal... Read more
High-Sensitivity Troponin Demonstrates Potential for Diagnosing Acute Coronary Syndrome
Chest pain is a common yet difficult symptom for general practitioners to assess, as it can stem from both serious and benign conditions. Now, a new study has found that high-sensitivity troponin tests... Read moreHematology
view channel
Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more
Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more
Microbiology
view channel
Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results
The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more
AST System Delivers Actionable Results for Gram-Negative Bacteria Directly from Positive Blood Cultures
Annually, sepsis claims the lives of 11 million people globally, with 1.3 million of these deaths linked to antibiotic-resistant bacteria. For clinicians, the ability to quickly and accurately interpret... Read more
Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours
Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more
New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics
On average, every four years a new virus emerges that poses a pandemic threat, in addition to numerous already known viruses that have the potential to jump across species. Currently, there is no test... Read morePathology
view channel
Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine
Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more (1)_2.jpg "Image: A cluster map of different prostate cancer patterns detected by the AI tool PATHOMIQ_PRAD from stained tissue images (Photo courtesy of Nair, et al. (2024), European Urology)")
Innovative AI Tool Uses Digitized Whole-Slide Images for Intermediate-Risk Prostate Management
Prostate cancer estimates for the United States in 2024 include approximately 299,010 new cases and about 35,250 deaths. Among patients in the intermediate-risk group, around 60% lack a clear treatment... Read more
AI-Based Tissue Staining Detects Amyloid Deposits Without Chemical Stains or Polarization Microscopy
Systemic amyloidosis, a disorder characterized by the buildup of misfolded proteins in organs and tissues, presents significant diagnostic difficulties. The condition affects millions of people each year,... Read more
Super-Resolution Imaging Detects Parkinson's 20 Years Before First Motor Symptoms Appear
Parkinson's disease is the second most common neurodegenerative disorder globally, affecting approximately 8.5 million people today. This debilitating condition is characterized by the destruction of ... Read moreTechnology
view channel
New Serological Pipet Controller Features Groundbreaking Repeat Dispense Ability
The conventional approach of using serological pipets for dispensing multiple aliquots is often slow, requiring constant attention to graduation marks and manual control for each dispense.... Read more
Breath-Based Sampling System Diagnoses Lower Respiratory Tract Infection
Lower Respiratory Tract Infections (LRTIs) are the leading cause of death from infectious diseases. Current diagnostic methods rely heavily on clinical symptoms but often lack specificity, particularly... Read more
POCT Device Monitors C-Reactive Protein Levels Associated with Inflammation in Real Time
Inflammation, a natural immune response, increases blood flow and improves cellular defense against diseases and infections. Rapid detection of inflammation is critical for effective treatment, creating... Read more
Industry
view channel
MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine
At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more.jpg "Image: The integration of Nova’s BioProfile FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum Flex (Photo courtesy of Terumo BCT)"){kind=small}
Nova Biomedical and Terumo BCT Collaborate on Automated Cell Culture Sensing
Nova Biomedical (Waltham, MA, USA) and Terumo Blood and Cell Technologies (Lakewood, CO, USA) have entered into a collaboration to enable automated cell culture sensing with Terumo BCT's Quantum Flex Cell... Read more
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Since 2022, Beckman Coulter (Brea, CA, USA) and Scopio Labs (Tel Aviv, Israel) have been working together to accelerate adoption of the next generation of digital cell morphology. Scopio's X100 and X100HT... Read more
